Reports that the United States Food and Drug Administration has licensed a rabies vaccine for both pre-exposure and postexposure prophylactic use in humans. Details on the purified chick embryo cell culture vaccine, called RabAvert; Earlier products that were licensed for use as rabies vaccines....
Such viruses could form the basis of future vaccines for rabies (reviewed by Hicks et al[41]) and one variant has been trialled as an oral vaccine for wildlife[42]. The method of attenuation falls into two categories. The first are those constructs that have a gene deletion, usually the...
RABV strains consists of two groups: street strains, which are field strains isolated from a human patient or an animal with rabies, and fixed strains, which include laboratory strains and vaccine strains established through multiple passages of street strains in cultured cells and/or animals. Compa...
Parenteral rabies vaccine, requires dog restraint with potential risk of bites Aggressive or overly shy dogs less likely to be brought to a MSP Depend on owner awareness of MSP clinic, and geographical accessibility Capture vaccinate release vaccination (CVR)*‡ Vaccinators are required to capture...
This suggests that people remain tolerant of dogs even with increasing numbers and that dog numbers are probably controlled by the availability of human derived food and thus human numbers rather than by the availability of other resources. The overall Iringa dog population was much larger than ...
Jentes ES, Blanton JD, Johnson KJ, Petersen BW, Lamias MJ, Robertson K et al (2013) The Global Availability of Rabies Immune Globulin and Rabies Vaccine in Clinics Providing Direct Care to Travelers. J Travel Med 20(3):148–158. https://doi.org/10.1111/jtm.12024 Article PubMed Google...
RABORAL V-RG® is an oral rabies vaccine bait that contains an attenuated (“modified-live”) recombinant vaccinia virus vector vaccine expressing the rabies virus glycoprotein gene (V-RG). Approximately 250 million doses have been distributed globally
Gives information on the purified chick embryo cell culture (PCEC) vaccine (RabAvert), which was licensed on October 20, 1997, by the United States Food and Drug Administration, as a rabies vaccine for the pre-exposure and postexposure prophylactic use in humans. Company which manufactures the...
Nagarajan T, Rupprecht CE, Dessain SK et al (2008) Human monoclonal antibody and vaccine approaches to prevent human rabies. In: Dessain SK (ed) Human antibody therapeutics for viral disease. Current topics in microbiology and immunology, vol 317. Springer, Berlin, Heidelberg. https://doi.org...
Animal and Plant Health Inspection Service on the availability of an environmental evaluation for oral rabies vaccination. It mentions that the environmental assessment examines the utilization of an experimental rabies vaccine in field safety and immunogenicity trials for New Hampshire, New York, Ohio, ...